vs
ASTRONICS CORP（ATRO）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
ASTRONICS CORP的季度营收约是Ultragenyx Pharmaceutical Inc.的1.2倍（$240.1M vs $207.3M），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 15.1%），ASTRONICS CORP自由现金流更多（$15.8M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 13.9%）
Astronics Corporation是一家成立于1968年的美国航空航天电子企业，总部位于纽约州东奥罗拉，在纳斯达克上市，股票代码为ATRO。该公司专注于军用、商用及公务机的照明与电子系统集成业务，同时还提供半导体测试系统，在相关领域拥有较高知名度。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
ATRO vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $240.1M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | 33.3% | — |
| 营业利润率 | 14.8% | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | 15.1% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $0.82 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $240.1M | $207.3M | ||
| Q3 25 | $211.4M | $159.9M | ||
| Q2 25 | $204.7M | $166.5M | ||
| Q1 25 | $205.9M | $139.3M | ||
| Q4 24 | $208.5M | $164.6M | ||
| Q3 24 | $203.7M | $139.5M | ||
| Q2 24 | $198.1M | $147.0M | ||
| Q1 24 | $185.1M | $108.8M |
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $-11.1M | $-180.4M | ||
| Q2 25 | $1.3M | $-115.0M | ||
| Q1 25 | $9.5M | $-151.1M | ||
| Q4 24 | — | $-133.2M | ||
| Q3 24 | $-11.7M | $-133.5M | ||
| Q2 24 | $1.5M | $-131.6M | ||
| Q1 24 | $-3.2M | $-170.7M |
| Q4 25 | 33.3% | — | ||
| Q3 25 | 30.5% | — | ||
| Q2 25 | 25.8% | — | ||
| Q1 25 | 29.5% | — | ||
| Q4 24 | 29.8% | — | ||
| Q3 24 | 27.1% | — | ||
| Q2 24 | 28.0% | — | ||
| Q1 24 | 25.7% | — |
| Q4 25 | 14.8% | -54.7% | ||
| Q3 25 | 10.9% | -106.9% | ||
| Q2 25 | 2.3% | -64.8% | ||
| Q1 25 | 6.4% | -102.6% | ||
| Q4 24 | 4.3% | -74.3% | ||
| Q3 24 | 4.1% | -94.6% | ||
| Q2 24 | 3.8% | -79.1% | ||
| Q1 24 | 0.9% | -151.9% |
| Q4 25 | — | -62.0% | ||
| Q3 25 | -5.2% | -112.8% | ||
| Q2 25 | 0.6% | -69.0% | ||
| Q1 25 | 4.6% | -108.5% | ||
| Q4 24 | — | -80.9% | ||
| Q3 24 | -5.8% | -95.7% | ||
| Q2 24 | 0.8% | -89.5% | ||
| Q1 24 | -1.7% | -156.8% |
| Q4 25 | $0.82 | $-1.28 | ||
| Q3 25 | $-0.31 | $-1.81 | ||
| Q2 25 | $0.04 | $-1.17 | ||
| Q1 25 | $0.26 | $-1.57 | ||
| Q4 24 | $-0.07 | $-1.34 | ||
| Q3 24 | $-0.34 | $-1.40 | ||
| Q2 24 | $0.04 | $-1.52 | ||
| Q1 24 | $-0.09 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.2M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $140.1M | $-80.0M |
| 总资产 | $706.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $18.2M | $421.0M | ||
| Q3 25 | $13.5M | $202.5M | ||
| Q2 25 | $13.5M | $176.3M | ||
| Q1 25 | $24.8M | $127.1M | ||
| Q4 24 | $9.3M | $174.0M | ||
| Q3 24 | $5.2M | $150.6M | ||
| Q2 24 | $2.9M | $480.7M | ||
| Q1 24 | $5.3M | $112.3M |
| Q4 25 | $140.1M | $-80.0M | ||
| Q3 25 | $108.9M | $9.2M | ||
| Q2 25 | $271.6M | $151.3M | ||
| Q1 25 | $266.8M | $144.2M | ||
| Q4 24 | $256.1M | $255.0M | ||
| Q3 24 | $249.2M | $346.8M | ||
| Q2 24 | $257.9M | $432.4M | ||
| Q1 24 | $251.7M | $140.3M |
| Q4 25 | $706.7M | $1.5B | ||
| Q3 25 | $682.2M | $1.2B | ||
| Q2 25 | $646.7M | $1.3B | ||
| Q1 25 | $662.2M | $1.3B | ||
| Q4 24 | $648.8M | $1.5B | ||
| Q3 24 | $651.6M | $1.5B | ||
| Q2 24 | $644.9M | $1.6B | ||
| Q1 24 | $630.0M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.6M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $15.8M | $-100.8M |
| 自由现金流率自由现金流/营收 | 6.6% | -48.6% |
| 资本支出强度资本支出/营收 | 4.9% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $43.1M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $27.6M | $-99.8M | ||
| Q3 25 | $34.2M | $-91.4M | ||
| Q2 25 | $-7.6M | $-108.3M | ||
| Q1 25 | $20.6M | $-166.5M | ||
| Q4 24 | $26.4M | $-79.3M | ||
| Q3 24 | $8.4M | $-67.0M | ||
| Q2 24 | $-6.3M | $-77.0M | ||
| Q1 24 | $2.0M | $-190.7M |
| Q4 25 | $15.8M | $-100.8M | ||
| Q3 25 | $21.0M | $-92.7M | ||
| Q2 25 | $-12.2M | $-110.7M | ||
| Q1 25 | $18.5M | $-167.8M | ||
| Q4 24 | $23.2M | $-79.5M | ||
| Q3 24 | $6.5M | $-68.6M | ||
| Q2 24 | $-8.1M | $-79.0M | ||
| Q1 24 | $439.0K | $-193.9M |
| Q4 25 | 6.6% | -48.6% | ||
| Q3 25 | 9.9% | -58.0% | ||
| Q2 25 | -6.0% | -66.5% | ||
| Q1 25 | 9.0% | -120.5% | ||
| Q4 24 | 11.1% | -48.3% | ||
| Q3 24 | 3.2% | -49.2% | ||
| Q2 24 | -4.1% | -53.7% | ||
| Q1 24 | 0.2% | -178.2% |
| Q4 25 | 4.9% | 0.5% | ||
| Q3 25 | 6.2% | 0.8% | ||
| Q2 25 | 2.2% | 1.5% | ||
| Q1 25 | 1.0% | 1.0% | ||
| Q4 24 | 1.5% | 0.1% | ||
| Q3 24 | 0.9% | 1.2% | ||
| Q2 24 | 0.9% | 1.4% | ||
| Q1 24 | 0.9% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -5.81× | — | ||
| Q1 25 | 2.17× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.08× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRO
| Product Line Electrical Power And Motion | $113.8M | 47% |
| Product Line Avionics | $32.0M | 13% |
| Military Aircraft | $28.0M | 12% |
| General Aviation | $22.3M | 9% |
| Government And Defense | $20.5M | 9% |
| Product Line Systems Certification | $13.2M | 6% |
| Product Line Structures | $3.7M | 2% |
| Product Line Other | $2.3M | 1% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
